PBSV Pharma-Bio Serv, Inc.
PBSV financial statements, revenue, balance sheet, cash flow, and SEC filings
▼ Company Profile
▼ Key Metrics (TTM)
As of Jul 31, 2026Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| Revenue | $9.00M | $9.51M | $16.98M |
| Cost of Revenue | $6.09M | $6.99M | $11.91M |
| Gross Profit | $2.91M | $2.52M | $5.07M |
| OPERATING EXPENSES | |||
| SG&A Expense | $3.55M | $3.80M | $3.95M |
| Operating Income | $-637.66K | $-1.29M | $1.12M |
| NON-OPERATING INCOME / EXPENSE | |||
| Interest Income | $37.53K | $245.82K | $320.08K |
| Other Income/Expense | $543.40K | $532.14K | $570.08K |
| Pretax Income | $-94.26K | $-755.45K | $1.69M |
| Income Tax | $6.20K | $22.17K | $377.31K |
| Net Income | $-100.46K | $-777.62K | $1.31M |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $0.00 | $-0.03 | $0.06 |
| Diluted Shares | 22.96M | 22.97M | 23.00M |
| EBITDA | $-577.80K | $-1.26M | $1.17M |
| Depreciation & Amortization | $59.87K | $23.31K | $48.09K |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $3.38M | $6.77M | $10.45M |
| Short-term Investments | $7.48M | $5.98M | $4.53M |
| Accounts Receivable | $2.36M | $2.51M | $3.94M |
| Current Assets | $13.39M | $15.70M | $19.40M |
| PP&E (Net) | $116.06K | $169.28K | $32.85K |
| Other Noncurrent Assets | $120.75K | $225.60K | $111.67K |
| Noncurrent Assets | $266.20K | $593.48K | $500.96K |
| Total Assets | $13.65M | $16.29M | $19.90M |
| LIABILITIES | |||
| Accounts Payable | $991.17K | $1.13M | $1.47M |
| Current Liabilities | $1.74M | $1.89M | $2.15M |
| Noncurrent Liabilities | $0 | $689.74K | $1.62M |
| Total Liabilities | $1.74M | $2.58M | $3.78M |
| EQUITY | |||
| Common Stock | $2.35K | $2.35K | $2.35K |
| Additional Paid-in Capital | $1.68M | $1.64M | $1.60M |
| Retained Earnings | $10.53M | $12.35M | $14.85M |
| Accumulated OCI | $278.05K | $262.38K | $210.27K |
| Total Equity | $11.91M | $13.72M | $16.13M |
| Total Liabilities & Equity | $13.65M | $16.29M | $19.90M |
| SUPPLEMENTAL | |||
| Shares Outstanding | 22.91M | 22.96M | 22.96M |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-214.89K | $-566.70K | $1.89M |
| Capital Expenditures | $6.64K | $159.74K | $7.25K |
| Cash from Investing | $-1.47M | $-1.36M | $-4.22M |
| Cash from Financing | $-1.75M | $-1.73M | $-1.76M |
| Free Cash Flow | $-221.53K | $-726.44K | $1.88M |
| Beginning Cash (CFS) | $6.77M | $10.45M | $14.46M |
| Net Change in Cash | $-3.43M | $-3.66M | $-4.09M |
| Effect of FX on Cash | $44.49K | $-17.63K | $68.87K |
| Calculated Ending Cash | $3.38M | $6.77M | $10.45M |
| Cash per BS | $3.38M | $6.77M | $10.45M |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $3.38M | $6.77M | $10.45M |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log InQuarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
What is Pharma-Bio Serv, Inc.'s annual revenue?
Pharma-Bio Serv, Inc. reported $9.48M in revenue for trailing twelve months (ending July 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.
Is Pharma-Bio Serv, Inc. profitable?
Yes. Pharma-Bio Serv, Inc. reported $251.53K in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.
Does Pharma-Bio Serv, Inc. generate free cash flow?
No. Free cash flow was $-421.36K for trailing twelve months. Operating cash flow was $-414.89K.
Fundamentals Hub